SLC16A13

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, SLC16A13 mutation is significantly associated with the RNA expression of many other genes, with 1,032 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible SLC16A13-associated genes across cancer lineages are RNU1-82P, LINC01501, and ANAPC15P2. Each is linked with SLC16A13 in more than 1 cancer types. Because this analysis shows association rather than direction, both SLC16A13-to-partner and partner-to-SLC16A13 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, RNU1-82P grouped by SLC16A13-low versus SLC16A13-high in CESC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (SLC16A13→partner) and Y-score (partner→SLC16A13) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
CESCRNU1-82P →+0.087+4.144.006.00932
CESCLINC01501 →+0.134+3.844.002.00432
CESCANAPC15P2 →+0.074+4.103.001.00232
UCECOR6K3 →+0.080+2.523.002.00832
UCECRNA5SP86 →+0.678+2.840<.001.00432
UCECRN7SKP286 →+0.057+4.360<.001.00432
Each partner links to its Q-omics profile. Showing the 6 strongest of 1,032 associations by consensus.

RNU1-82P by SLC16A13 expression — CESC

Box plot of RNU1-82P in SLC16A13-low vs SLC16A13-high samples in CESC.

Explore this box plot interactively →

Exploration